@FierceBiotech: Biogen's Scangos earns Icahn's (rare) blessing. Report | Follow @FierceBiotech
@JohnCFierce: And so the hunter becomes the hunted. Valeant makes $5.7B hostile bid for Cephalon. | Follow @JohnCFierce
> Faced with a storm of protest over KV Pharma's $1,500 price tag for the newly approved Makena, which had been sold by compounding pharmacies for about $15, the FDA issued a statement that clears the way for compounding pharmacies to compete at their much lower generic price. The statement included a reference to the broad support the NIH had offered in developing Makena, a slap in the face for a developer which almost overnight became the poster child for drug price gouging. Story
> Bavarian Nordic has submitted an app for its smallpox vaccine Imvamune in Canada. Story
> LigoCyte Pharmaceuticals is considering the possibility of building a new manufacturing center in Bozeman, Montana. Report
> Rules Based Medicine is developing what it says is the first blood test for schizophrenia. The test, called VeriPsych, was developed with Cambridge University and relies on 51 biomarkers. Report
> BG Medicine and Boston Scientific are partnering on patient-screening technology for cardiac-resynchronization therapy (CRT). Story
> Dortmund, Germany-based Protagen is continuing its mission to partner with other companies on biomarker discovery. The latest is a deal with Biogen Idec to discover biomarkers for relapsing or remitting multiple sclerosis. Story
Pharma News
> Merck KGaA tries again on Erbitux for lung cancer. Report
> NICE nixes Bristol's arthritis med for NHS use. Story
> GSK partner holds off generic rival for Lovaza. Article
> J&J recalls more drugs made at troubled plant. News
Drug Delivery News
> Nano 'mummies' a real horror show for infections. Article
> Next-gen nanoparticle can image, deliver, heat and destroy. News
> Stapled peptides 'herald a new era' for pharma. Story
> When nature calls, some drug designers listen. Item
> MicroCHIPS granted new patent for implantable device. Article
> Gold nanoparticles deliver DOX directly to cancer. Report
Medical Device News
> Boston Scientific's CEO pay nosedived in 2010. Report
> CryoLife buys Cardiogenesis for $22M. Article
> Report: St. Jude hitting new highs. Item
> FDA redefines 510(k) special controls. News
> Device uses submarine tech to detect stroke. Article
> GI Dynamics advances weight loss advice. Story
> Coloplast looks to maintain growth. Story
And Finally... Two engineers at Harvard and MIT have developed a device that can detect a single cancer cell in a blood sample. Release